RT @officialEANM: Plaidoyer for theranostics approach: calling for image-based selection of patients for PSMA-directed radioligand therapy…
RT @officialEANM: Plaidoyer for theranostics approach: calling for image-based selection of patients for PSMA-directed radioligand therapy…
RT @officialEANM: Plaidoyer for theranostics approach: calling for image-based selection of patients for PSMA-directed radioligand therapy…
RT @officialEANM: Plaidoyer for theranostics approach: calling for image-based selection of patients for PSMA-directed radioligand therapy…
RT @officialEANM: Plaidoyer for theranostics approach: calling for image-based selection of patients for PSMA-directed radioligand therapy…
Plaidoyer for theranostics approach: calling for image-based selection of patients for PSMA-directed radioligand therapy with Lutetium-177 ([177Lu]Lu-PSMA-RLT). #EANM could not agree more with the publication of #nucmed & urology @TheLancetOncol expert
RT @radiolobt: EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT) https://t.co/78YV70uTs5
RT @radiolobt: EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT) https://t.co/78YV70uTs5
RT @radiolobt: EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT) https://t.co/78YV70uTs5
EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT) https://t.co/78YV70uTs5